InvestorsObserver
×
News Home

Does Avidity Biosciences Inc (RNA) Have What it Takes to be in Your Portfolio Monday?

Monday, March 25, 2024 12:11 PM | InvestorsObserver Analysts

Mentioned in this article

Does Avidity Biosciences Inc (RNA) Have What it Takes to be in Your Portfolio Monday?

A rating of 96 puts Avidity Biosciences Inc (RNA) near the top of the Biotechnology industry according to InvestorsObserver. Avidity Biosciences Inc's score of 96 means it scores higher than 96% of stocks in the industry. Avidity Biosciences Inc also received an overall rating of 84, putting it above 84% of all stocks. Biotechnology is ranked 20 out of the 148 industries.

Overall Score - 84
RNA has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on RNA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Avidity Biosciences Inc Stock Today?

Avidity Biosciences Inc (RNA) stock is trading at $22.94 as of 12:10 PM on Monday, Mar 25, a decline of -$0.76, or -3.21% from the previous closing price of $23.70. The stock has traded between $22.93 and $24.22 so far today. Volume today is low. So far 286,243 shares have traded compared to average volume of 1,396,125 shares. Click Here to get the full Stock Report for Avidity Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App